| Accession number |
System name |
1H shifts |
13C shifts |
15N shifts |
31P shifts |
Protein |
DNA |
RNA |
| 19222 |
Four dodecamers that together cover 39 bp of the 5' half of the strong nucleosome positioning sequence 601 |
0 |
0 |
0 |
88 |
|
X |
|
| 26568 |
The structure of the SOLE element of oskar mRNA |
251 |
213 |
38 |
30 |
|
|
X |
| 15869 |
single polyribonucleotide |
272 |
270 |
47 |
29 |
|
|
X |
| 4172 |
Rev-erb beta response element |
268 |
0 |
0 |
28 |
|
X |
|
| 6509 |
ScYLV RNA pseudoknot |
263 |
217 |
96 |
28 |
|
|
X |
| 19018 |
E. coli ribosomela decoding site with apramycin |
262 |
256 |
101 |
27 |
|
|
X |
| 5134 |
dAAUAA DNA Bulge: 5'-D(*GP*CP*AP*TP*CP*GP*AP*AP*UP*AP*AP*GP*CP*TP*AP*CP*G)-3' |
248 |
0 |
0 |
27 |
|
X |
|
| 4555 |
SRY-14mer duplex |
243 |
0 |
0 |
26 |
|
X |
|
| 5135 |
dAATAA DNA Bulge: 5'-D(*GP*CP*AP*TP*CP*GP*AP*AP*TP*AP*AP*GP*CP*TP*AP*CP*G)-3' |
241 |
0 |
0 |
26 |
|
X |
|
| 18279 |
human CEB25 minisatellite G-quadruplex |
233 |
56 |
0 |
25 |
|
X |
|
| 17129 |
25-mer DNA oligomer |
254 |
139 |
0 |
25 |
|
X |
|
| 15527 |
Mbp1_14 |
227 |
116 |
0 |
25 |
|
X |
|
| 36168 |
DNA (5'-D(*GP*GP*GP*TP*AP*CP*CP*CP*GP*GP*GP*TP*GP*AP*GP*GP*TP*GP*CP*GP*GP*GP*GP*T)-3') |
236 |
11 |
0 |
24 |
|
X |
|
| 19387 |
intramolecular (3+1) human telomeric G-quadruplex bound to a telomestatin derivative |
240 |
0 |
0 |
23 |
|
X |
|
| 15360 |
DNA 12mer |
266 |
0 |
0 |
22 |
|
X |
|
| 5671 |
5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' |
0 |
0 |
0 |
22 |
|
X |
|
| 34159 |
DNA (5'-D(*CP*GP*AP*TP*GP*TP*AP*CP*AP*TP*CP*G)-3') |
274 |
131 |
0 |
22 |
|
X |
|
| 25604 |
double base-pair inversion mutant of murine tumour necrosis factor alpha CDE-23 RNA |
180 |
151 |
0 |
22 |
|
|
X |
| 4415 |
DNA dodecamer duplex |
193 |
0 |
0 |
22 |
|
X |
|
| 4416 |
Cis-syn thymine cyclobutane dimer |
193 |
0 |
0 |
22 |
|
X |
|
| 30253 |
DNA (5'-D(*GP*CP*AP*TP*CP*GP*AP*TP*TP*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*AP*AP*TP*CP*GP*AP*TP*GP*C)-3') |
155 |
113 |
10 |
22 |
|
X |
|
| 34158 |
DNA (5'-D(*CP*GP*AP*TP*GP*TP*AP*CP*AP*TP*CP*G)-3') |
237 |
130 |
0 |
22 |
|
X |
|
| 34157 |
DNA (5'-D(*CP*GP*AP*TP*GP*TP*AP*CP*AP*TP*CP*G)-3') |
281 |
131 |
0 |
22 |
|
X |
|
| 19159 |
d(GGGGTTGGGGTTTTGGGGAAGGGG) quadruplex |
224 |
0 |
0 |
22 |
|
X |
|
| 30254 |
DNA (5'-D(*CP*GP*AP*TP*TP*TP*TP*TP*TP*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*AP*AP*AP*AP*AP*AP*TP*CP*G)-3') |
161 |
115 |
10 |
22 |
|
X |
|
| 4816 |
INFLUENZA A VIRUS PROMOTER RNA |
224 |
39 |
23 |
22 |
|
|
X |
| 4692 |
TELOMERE FRAGMENT |
239 |
0 |
0 |
21 |
|
X |
|
| 30224 |
phage GA operator RNA hairpin |
196 |
158 |
49 |
21 |
|
|
X |
| 25603 |
murine tumour necrosis factor alpha CDE RNA |
185 |
148 |
33 |
21 |
|
|
X |
| 18981 |
DNA duplex containing a cluster of mutagenic 8-oxo-guanine and abasic site lesion |
185 |
0 |
0 |
21 |
|
X |
|
| 16225 |
5'-D(*DGP*DTP*DGP*DCP*DGP*(TG)P*DGP*DTP*DTP*DTP*DGP*DT)-3' |
231 |
0 |
0 |
20 |
|
X |
|
| 18984 |
DNA containing a cluster of 8-oxo-guanine and abasic site lesion : beta anomer |
182 |
0 |
0 |
20 |
|
X |
|
| 17406 |
5'-R(*GP*UP*GP*AP*AP*GP*CP*CP*CP*GP*U)-3' |
156 |
24 |
8 |
20 |
|
|
X |
| 18040 |
DNA_1 |
202 |
0 |
0 |
20 |
|
X |
|
| 18973 |
DNA duplex containing a cluster of mutagenic 8-oxo-guanine and abasic site lesion |
179 |
0 |
0 |
20 |
|
X |
|
| 18985 |
DNA_1 |
182 |
0 |
0 |
20 |
|
X |
|
| 30255 |
DNA (5'-D(*CP*GP*AP*TP*TP*TP*TP*TP*TP*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*(M1A)P*AP*AP*AP*AP*AP*TP*CP*G)-3') |
160 |
115 |
10 |
20 |
|
X |
|
| 18979 |
DNA containing a cluster of 8-oxo-guanine and abasic site lesion : beta anomer |
179 |
0 |
0 |
20 |
|
X |
|
| 27770 |
Branchpoint duplex with U2 snRNA site |
153 |
35 |
0 |
19 |
|
|
X |
| 4175 |
SL3 RNA hairpin |
175 |
0 |
0 |
19 |
|
|
X |
| 27769 |
Branchpoint duplex with pseudoU U2 snRNA site |
150 |
36 |
0 |
19 |
|
|
X |
| 17887 |
alpha anomeric lesion |
177 |
56 |
0 |
18 |
|
X |
|
| 6979 |
5'-R(*GP*GP*UP*GP*AP*AP*GP*GP*CP*U)-3'/5'-R(*GP*CP*CP*GP*AP*AP*GP*CP*CP*(PR5))-3' |
168 |
0 |
0 |
18 |
|
|
X |
| 5553 |
C4 promoter of influneza A virus |
202 |
29 |
11 |
18 |
|
|
X |
| 30054 |
DNA (5'-D(*CP*GP*(SSG)P*CP*CP*GP*CP*CP*GP*A)-3'), DNA (5'-D(*TP*CP*GP*GP*CP*GP*(SSG)P*CP*CP*G)-3') |
112 |
0 |
0 |
18 |
|
X |
|
| 19158 |
DNA (5'-D(*GP*GP*GP*TP*TP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*TP*GP*GP*G)-3') |
181 |
0 |
0 |
18 |
|
X |
|
| 4141 |
vnd/NK-2 homeodomain DNA complex |
840 |
291 |
100 |
18 |
X |
X |
|
| 30052 |
DNA (5'-D(*CP*GP*(RSG)P*CP*CP*GP*CP*CP*GP*A)-3'), DNA (5'-D(*TP*CP*GP*GP*CP*GP*(RSG)P*CP*CP*G)-3') |
144 |
0 |
0 |
18 |
|
X |
|
| 7090 |
18 mer hairpin hexaloop |
149 |
90 |
21 |
17 |
|
|
X |
| 5256 |
Anticodon Stem-loop of tRNA(Phe) |
126 |
110 |
16 |
17 |
|
|
X |
| 4646 |
DNA |
144 |
0 |
0 |
17 |
|
X |
|
| 15571 |
RNA DUPLEX |
182 |
124 |
0 |
17 |
|
|
X |
| 6062 |
NRS23 |
198 |
153 |
15 |
17 |
|
|
X |
| 17520 |
Unmodified ASL_Tyr |
136 |
116 |
41 |
16 |
|
|
X |
| 34324 |
RNA duplex containing pseudouridine residue |
155 |
83 |
0 |
16 |
|
|
X |
| 30117 |
DNA/RNA (5'-D(*TP*TP*AP*G)-R(P*G)-D(P*CP*CP*TP*G)-3'), DNA (5'-D(*CP*AP*GP*GP*CP*CP*TP*AP*A)-3') |
128 |
0 |
0 |
16 |
|
X |
|
| 30113 |
DNA/RNA (5'-D(*AP*TP*CP*C)-R(P*G)-D(P*GP*TP*AP*G)-3'), DNA (5'-D(*CP*TP*AP*CP*CP*GP*GP*AP*T)-3') |
128 |
0 |
0 |
16 |
|
X |
|
| 30112 |
DNA (5'-D(*TP*TP*AP*GP*GP*CP*CP*TP*G)-3'), DNA (5'-D(*CP*AP*GP*GP*CP*CP*TP*AP*A)-3') |
129 |
0 |
0 |
16 |
|
X |
|
| 4135 |
RNA duplex including the C-U mismatch |
130 |
0 |
1 |
16 |
|
|
X |
| 25723 |
Universal Base oligonucleotide with UB at point 5 |
136 |
0 |
0 |
16 |
|
X |
|
| 25724 |
Control DNA oligonucleotide for the universal base |
133 |
0 |
0 |
16 |
|
X |
|
| 6562 |
D-loop from cloverleaf 1 of bovine enterovirus 1 RNA |
155 |
120 |
47 |
16 |
|
|
X |
| 30116 |
DNA/RNA (5'-D(*AP*TP*CP*C)-R(P*G)-D(P*GP*TP*AP*G)-3'), DNA (5'-D(*CP*TP*AP*CP*CP*GP*GP*AP*T)-3') |
128 |
0 |
0 |
16 |
|
X |
|
| 4547 |
DNA/RNA |
168 |
0 |
0 |
16 |
|
X |
X |
| 17535 |
DNA/RNA hybrid |
130 |
36 |
0 |
16 |
|
X |
X |
| 30105 |
DNA/RNA (5'-D(*AP*TP*GP*GP*A)-R(P*G)-D(P*CP*TP*C)-3'), DNA (5'-D(*GP*AP*GP*CP*TP*CP*CP*AP*T)-3') |
128 |
0 |
0 |
16 |
|
X |
|
| 30111 |
DNA (5'-D(*AP*TP*CP*CP*GP*GP*TP*AP*G)-3'), DNA (5'-D(*CP*TP*AP*CP*CP*GP*GP*AP*T)-3') |
129 |
0 |
0 |
16 |
|
X |
|
| 30114 |
DNA/RNA (5'-D(*TP*TP*AP*G)-R(P*G)-D(P*CP*CP*TP*G)-3'), DNA (5'-D(*CP*AP*GP*GP*CP*CP*TP*AP*A)-3') |
128 |
0 |
0 |
16 |
|
X |
|
| 30115 |
DNA/RNA (5'-D(*AP*TP*GP*GP*A)-R(P*G)-D(P*CP*TP*C)-3'), DNA (5'-D(*GP*AP*GP*CP*TP*CP*CP*AP*T)-3') |
128 |
0 |
0 |
16 |
|
X |
|
| 30053 |
DNA (5'-D(*CP*GP*GP*CP*CP*GP*CP*CP*GP*A)-3'), DNA (5'-D(*TP*CP*GP*GP*CP*GP*GP*CP*CP*G)-3') |
156 |
0 |
0 |
16 |
|
X |
|
| 34323 |
RNA duplex containing pseudouridine residue |
155 |
90 |
0 |
16 |
|
|
X |
| 17517 |
Anticodon Stem-loop of Bacillus subtilis tRNATYR |
80 |
35 |
0 |
16 |
|
|
X |
| 6430 |
HIV-1 integrase inhibitor, 93del |
148 |
0 |
0 |
15 |
|
X |
|
| 18239 |
RNA (5'-R(*GP*AP*GP*GP*AP*CP*AP*UP*AP*GP*AP*UP*CP*UP*UP*C)-3') |
105 |
0 |
0 |
15 |
|
|
X |
| 15376 |
modified DNA duplex |
170 |
0 |
0 |
15 |
|
X |
|
| 15781 |
5'-R(*GP*UP*CP*GP*UP*GP*CP*UP*G)-3' |
148 |
110 |
0 |
15 |
|
|
X |
| 30038 |
DNA |
162 |
0 |
0 |
14 |
|
X |
|
| 18240 |
Mutant of the sub-genomic promoter from Brome Mosaic Virus |
100 |
0 |
0 |
14 |
|
|
X |
| 30044 |
DNA Dodecamer with 8-oxoguanine at 10th Position |
162 |
0 |
0 |
14 |
|
X |
|
| 5259 |
Anticodon Stem-loop of tRNA(Phe) |
114 |
102 |
13 |
14 |
|
|
X |
| 6009 |
Thrombin-binding DNA aptamer |
162 |
0 |
0 |
14 |
|
X |
|
| 5705 |
UUCG tetraloop |
140 |
132 |
47 |
14 |
|
|
X |
| 25415 |
3' splice site influenza A: 19-nt duplex |
140 |
0 |
0 |
14 |
|
|
X |
| 19440 |
N-[4,9,13-triazatridecan-1-yl]-2-deoxycytidine modified duplex DNA |
136 |
0 |
0 |
14 |
|
X |
|
| 4556 |
SRY-8mer duplex |
137 |
0 |
0 |
14 |
|
X |
|
| 19441 |
spermine modified DNA duplex |
141 |
0 |
0 |
14 |
|
X |
|
| 5528 |
RNA (25-MER):the complementary RNA promoter of influenza a virus |
219 |
0 |
0 |
13 |
|
|
X |
| 16714 |
AUCG tetraloop hairpin |
104 |
104 |
30 |
13 |
|
|
X |
| 30268 |
RNA (5'-R(*CP*CP*AP*GP*AP*AP*AP*CP*GP*GP*AP*UP*GP*GP*A)-3') |
88 |
0 |
0 |
13 |
|
|
X |
| 5245 |
5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3' |
109 |
0 |
0 |
13 |
|
X |
|
| 34321 |
RNA (31-MER) |
242 |
207 |
77 |
11 |
|
|
X |
| 34328 |
DNA (5'-*(DC5)P*GP*AP*TP*(P)P*TP*AP*(Z)P*AP*TP*CP*(DG3))-3') |
98 |
72 |
0 |
11 |
|
X |
|
| 19290 |
NMR structure of human TDP-43 tandem RRMs in complex with UG-rich RNA |
1155 |
864 |
182 |
11 |
X |
|
X |
| 30473 |
Sp1 transcription factor duplex 5'-d(GGGGCGGGG) |
164 |
70 |
0 |
10 |
|
X |
|
| 4243 |
DNA (5'-D(TCCCGTTTCCA)-3') |
84 |
0 |
0 |
10 |
|
X |
|
| 6273 |
GTTCACAGAAC DNA hairpin |
101 |
0 |
0 |
10 |
|
X |
|
| 16951 |
5'-R(*GP*AP*CP*AP*AP*GP*UP*GP*UP*CP*A)-3' |
107 |
50 |
0 |
10 |
|
|
X |
| 16952 |
5'-R(*GP*AP*CP*AP*AP*GP*UP*GP*UP*CP*A)-3' |
95 |
29 |
5 |
10 |
|
|
X |
| 16950 |
5'-R(*GP*AP*CP*AP*AP*GP*UP*GP*UP*CP*A)-3' |
85 |
29 |
4 |
10 |
|
|
X |
| 15572 |
RNA DUPLEX CONTAINING SINGLE ADENOSINE BULGE |
87 |
57 |
0 |
10 |
|
|
X |
| 25414 |
3' splice site influenza A: 11-nt hairpin |
97 |
0 |
0 |
10 |
|
|
X |
| 4244 |
alphaT decamer duplex |
94 |
0 |
0 |
9 |
|
X |
|
| 16609 |
rna-ligand complex |
205 |
180 |
27 |
9 |
|
|
X |
| 18050 |
DNA_1 |
179 |
0 |
0 |
9 |
|
X |
|
| 25220 |
RNA duplex |
83 |
28 |
0 |
9 |
|
|
X |
| 4235 |
DNA decamer |
82 |
0 |
0 |
9 |
|
X |
|
| 25534 |
26mer Box C/D RNA (5'-R(P*CP*UP*GP*AP*GP*CP*UP*CP*GP*AP*AP*AP*GP*AP*GP*CP*AP*AP*UP*GP*AP*UP*G)-3') |
0 |
173 |
49 |
9 |
|
|
X |
| 19784 |
G-triplex truncated-TBA |
119 |
66 |
0 |
9 |
|
X |
|
| 25526 |
RNA 27-MER, RIBOSTAMYCIN |
205 |
180 |
27 |
8 |
|
|
X |
| 16953 |
5'-R(*GP*AP*CP*AP*AP*GP*UP*GP*UP*CP*A)-3' |
81 |
19 |
0 |
8 |
|
|
X |
| 5681 |
CYCLIC OLIGONUCLEOTIDE D(CGCTCATT) |
91 |
0 |
0 |
8 |
|
X |
|
| 25291 |
RNA duplex |
77 |
48 |
0 |
8 |
|
|
X |
| 5588 |
5'-R(*GP*GP*CP*(P5P)P*(P5P)P*GP*CP*CP*U)-3' |
80 |
0 |
0 |
8 |
|
|
X |
| 5614 |
5'-R(*GP*GP*CP*AP*AP*GP*CP*CP*U)-3' |
77 |
0 |
0 |
8 |
|
|
X |
| 5586 |
5'-R(*GP*GP*CP*(P5P)P*AP*GP*CP*CP*U)-3' |
77 |
0 |
0 |
8 |
|
|
X |
| 5587 |
5'-R(*GP*GP*CP*AP*(P5P)P*GP*CP*CP*U)-3' |
77 |
0 |
0 |
8 |
|
|
X |
| 4753 |
D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND ZINC |
135 |
96 |
0 |
7 |
|
X |
|
| 16286 |
d(CGAGCTCG)2 |
46 |
0 |
0 |
7 |
|
X |
|
| 15780 |
5'-R(*GP*UP*CP*GP*AP*GP*CP*UP*G)-3' |
72 |
52 |
0 |
7 |
|
|
X |
| 4746 |
D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT |
127 |
80 |
0 |
7 |
|
X |
|
| 4361 |
chromomycin-DNA complex |
152 |
80 |
0 |
7 |
|
X |
|
| 4362 |
chromomycin-DNA complex |
160 |
96 |
0 |
7 |
|
X |
|
| 15898 |
DNA GAAA tetraloop |
72 |
42 |
0 |
7 |
|
X |
|
| 16282 |
d(AGAGCTCT)2 |
48 |
0 |
0 |
7 |
|
X |
|
| 16289 |
d(GCTATAGC)2 |
48 |
0 |
0 |
7 |
|
X |
|
| 25669 |
self complementary Xylonucleic Acid duplex |
74 |
72 |
0 |
7 |
|
|
X |
| 25661 |
rna-ligand complex |
307 |
265 |
117 |
7 |
|
|
X |
| 34265 |
RNA (5'-R(*UP*GP*GP*UP*GP*GP*U)-3') |
67 |
44 |
0 |
7 |
|
|
X |
| 30546 |
RNA (5'-R(*CP*GP*CP*AP*GP*CP*UP*UP*AP*CP*GP*C)-3'), RNA (5'-R(*GP*CP*GP*UP*GP*CP*UP*UP*UP*GP*CP*G)-3') |
148 |
24 |
0 |
7 |
|
|
X |
| 5282 |
5'-D(*GP*CP*GP*AP*AP*GP*C)-3' |
68 |
35 |
9 |
6 |
|
X |
|
| 30547 |
RNA (5'-R(*CP*GP*GP*GP*CP*AP*UP*CP*CP*G)-3') |
88 |
18 |
0 |
5 |
|
|
X |
| 19734 |
fd bacteriophage |
0 |
39 |
0 |
5 |
X |
X |
|
| 4894 |
MATERNAL EFFECT PROTEIN (STAUFEN)/RNA COMPLEX |
681 |
345 |
93 |
4 |
X |
|
X |
| 17309 |
coronavirus stem-loop 2 |
123 |
35 |
0 |
4 |
|
|
X |
| 15033 |
cyclic octamer |
43 |
20 |
0 |
4 |
|
X |
|
| 26842 |
TMR-3_48nt-5-TAMRA |
415 |
382 |
157 |
3 |
|
|
X |
| 6145 |
3LII in DMSO |
60 |
0 |
0 |
2 |
X |
|
|
| 6146 |
nisin/3LII complex |
236 |
73 |
34 |
2 |
X |
|
|
| 4898 |
complex of the FYVE domain of EEA1 with PtdIns3P |
542 |
383 |
109 |
2 |
X |
|
|
| 17941 |
IV-B_RNA |
243 |
179 |
47 |
2 |
|
|
X |
| 5703 |
U6 snRNA intramolecular stem loop |
204 |
66 |
0 |
1 |
|
|
X |
| 18656 |
Internal Loop 5'GAGU/3'UGAG |
0 |
0 |
0 |
0 |
|
|
|
